TitrateHQ: Intelligent ADHD Medication Log & Wear-off Tracker
Patients undergoing ADHD medication titration face mid-day effectiveness drop-offs and severe crashes, leading them to consume excess caffeine or double up on doses out of anxiety, which risks tolerance and early script depletion without objective data to show their doctor.
Is the problem real?
A newly diagnosed ADHD patient struggles with medication tolerance/wearing off too quickly, leading to anxiety about dependency and unhealthy coping mechanisms like excessive caffeine intake.
EVIDENCE
Addiction to meds or just the journey?
Addiction to meds or just the journey?
Addiction to meds or just the journey?
Who feels this pain?
TARGET USERS
Adults recently prescribed stimulant medication working with their psychiatrist to find effective dosage and timing while avoiding tolerance and crash issues.
Context
Current Workarounds
Where's the gap?
EXISTING SOLUTION GAPS
OPPORTUNITY & VALUE
Repeated complaints regarding rapid medication wear-off, accidental early booster usage, script running out early, and heavy caffeine compensation.
Purpose-built specifically for ADHD stimulant dynamics (ER/IR boosters, crash curves, tolerance anxiety) rather than generic mood or medication reminders.
A mobile-first companion app that tracks medication intake, daily symptom levels, side effects, and caffeine usage to generate clear 'wear-off profiles' and clinical reports for monthly psychiatrist reviews.
How does it make money?
MONETIZATION
Model
Patients are anxious about medication failure, losing scripts early, or developing addiction, and will gladly pay a nominal monthly fee to optimize their expensive prescriptions and avoid wasting doctor visits.
How do you ship it?
MVP PLAN
“Track your ADHD titration and eliminate afternoon crash guesswork in 30 days.”
A mobile-first companion app that tracks medication intake, daily symptom levels, side effects, and caffeine usage to generate clear 'wear-off profiles' and clinical reports for monthly psychiatrist reviews.
Core Features
Weekly Roadmap
- •Set up local data store and authentication
- •Build 1-tap dosage and booster logging interface
- •Implement quick crash/effectiveness rating prompt
- •Build caffeine input logger alongside dose records
- •Generate daily symptom/wear-off visual timeline chart
- •Implement push notifications for dosage wear-off check-ins
- •Create doctor-ready monthly summary PDF exporter
- •Integrate Stripe subscription paywall
- •Onboard 20 ADHD beta testers from online communities
- •Submit iOS and Android builds to app stores
- •Launch launch post on r/ADHD and ADHD creator channels
- •Monitor trial conversion rate and logging retention
Direct-to-consumer launch through ADHD communities (r/ADHD, r/adhdwomen, X ADHD advocates) paired with downloadable clinical summary templates shared with psychiatric providers.
RISKS & ASSUMPTIONS
Top Risks
App insights must strictly report historical user data without providing algorithmic dosing or timing recommendations that imply medical advice.
Users may cancel once their medication dose stabilizes, requiring continuous acquisition of newly diagnosed patients.
Users struggling with executive function may abandon complex daily logging if entry requires more than 2-3 seconds.
Should you build it?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 3 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "analytics", "cost-reduction", "healthcare", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "TitrateHQ: Intelligent ADHD Medication Log & Wear-off Tracker" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for analytics?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.